SCHEMBL9944281

SCHEMBL9944281

CC(C)(C)/C=N/OCCOc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.47
PKM P14618 2/20 0.43
PPARA Q07869 3/20 0.43
HTR1B P28222 2/20 0.43
HTR1D P28221 1/20 0.43
TAAR1 Q96RJ0 1/20 0.42
ALDH1A1 P00352 1/20 0.42
RECQL P46063 1/20 0.42
LTA4H P09960 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
RAB9A P51151 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944307 0.91 KCNA3 (0.50) KCNA3PPARAHTR1BHTR1DTAAR1
SCHEMBL15865982 0.81 KCNA3 (0.50) KCNA3PKMHTR1BHTR1DTAAR1
SCHEMBL9945420 0.79 KCNA3 (0.47) KCNA3PKMHTR1BHTR1DTAAR1
SCHEMBL9944291 0.76 TAAR1 (0.49) PPARATAAR1ALDH1A1RAB9ANPC1
SCHEMBL9944297 0.75 MAPK1 (0.38) KCNA3PKMPPARAALDH1A1LTA4H
SCHEMBL29638993 0.73 LTA4H (0.57) KCNA3PKMPPARALTA4HCHRNB2
SCHEMBL4142243 0.73 LTA4H (0.57) KCNA3PKMPPARALTA4HCHRNB2
SCHEMBL27962 0.73 KCNA3 (0.82) KCNA3PKMHTR1BHTR1DTAAR1
SCHEMBL15866002 0.73 KCNA3 (0.54) KCNA3HTR1BHTR1DTAAR1ALDH1A1
SCHEMBL1754085 0.72 KCNA3 (0.58) KCNA3PKMPPARAHTR1BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8772290-B2 Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same Oscotech Inc. (KR) 2014-07-08 US disclosed
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME OSCOTEC INC. (KR) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149707-A1 ALPHA-ARYLMETHOXYACRYLATE DERIVATIVE, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME HIF1A, HIF1AN, EGLN3 KCNA3 3595/4885PKM 338/4885PPARA 23/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.